- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Graft-versus-host Disease (cGVHD) in New Zealand
Total 648 results
-
XenikosNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsTerminatedSteroid-Refractory Acute Graft Versus Host DiseaseUnited States
-
Incyte CorporationTerminatedChronic Graft-versus-host DiseaseUnited States, Spain, France, Canada, Israel, United Kingdom, Germany, Italy, Denmark, Sweden, Finland, Belgium, Poland, Greece, Austria, Switzerland
-
Kadmon, a Sanofi CompanyTerminatedEfficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic TherapyChronic Graft-versus-host-diseaseUnited States
-
Mesoblast, Inc.CompletedGraft Versus Host DiseaseUnited States, Italy, Australia, Canada, Switzerland, United Kingdom
-
XenikosNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsTerminatedSteroid-Refractory Acute Graft Versus Host DiseaseUnited States, Belgium, Croatia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Roswell Park Cancer InstituteCompletedGraft Versus Host DiseaseUnited States
-
Therakos, Inc., a Mallinckrodt CompanyTerminatedSteroid Refractory Acute Graft Versus Host DiseaseUnited States, Spain, France, Austria, Germany, Hungary, Italy, United Kingdom
-
Hackensack Meridian HealthTerminatedGraft Versus Host DiseaseUnited States
-
University of British ColumbiaActive, not recruitingChronic Graft vs Host DiseaseCanada, United States, Austria
-
SoligenixTerminatedChronic Gastrointestinal Graft vs Host DiseaseUnited States
-
John LevineNational Cancer Institute (NCI)CompletedGVHD | Graft-versus-host-diseaseUnited States
-
Mesoblast, Inc.CompletedGraft Versus Host DiseaseUnited States, Australia, Canada
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedGraft Versus Host Disease | Hematopoietic Cell Transplantation RecipientUnited States
-
Fred Hutchinson Cancer CenterFacet BiotechUnknownGraft-vs-Host DiseaseUnited States
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedGraft-versus-Host Disease | Immune System DisordersUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Mesoblast, Inc.No longer availableGraft vs Host Disease | Graft-Versus-Host DiseaseUnited States, Canada
-
MedImmune LLCCompletedGraft Versus Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterSanofiRecruitingChronic Graft Versus Host DiseaseUnited States
-
Cynata Therapeutics LimitedRecruitingGraft Versus Host Disease, AcuteUnited States, Australia, Turkey
-
Millennium Pharmaceuticals, Inc.CompletedHematopoietic Stem CellsUnited States, Spain, Taiwan, Australia, Canada, Singapore, Korea, Republic of, Mexico, Switzerland, Japan, Germany, Norway, Israel, Russian Federation, Hungary, United Kingdom, Italy, Romania, Brazil, France, Austria, Belgium, Port... and more
-
Stanford UniversityNovartisCompletedLymphoma, Non-Hodgkin | Lymphoma, T-Cell, Peripheral | Bone Marrow Transplant FailureUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLymphoma | Leukemia | Hematopoietic and Lymphoid System NeoplasmUnited States, Canada
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Washington... and other collaboratorsActive, not recruiting
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Graft Versus Host DiseaseUnited States, Canada
-
Pharmacyclics LLC.Janssen Research & Development, LLCActive, not recruitingChronic Graft Versus Host DiseaseUnited States, Spain, Korea, Republic of, Australia, Austria, Canada, France, Germany, Israel, Italy, Netherlands, Russian Federation, United Kingdom
-
Martin, PaulNational Cancer Institute (NCI)TerminatedCancerUnited States, Canada
-
SanofiRecruitingChronic Graft Versus Host DiseaseAustralia, Argentina, Belgium, Spain, Sweden, Czechia, United Kingdom, United States, Italy, Germany, Canada, Israel, Denmark, Brazil
-
University of British ColumbiaRecruitingLeukemia | Allogeneic Hematopoietic Stem Cell Transplantation | Blood Cancer | Chronic Graft-versus-Host-Disease | Non-Malignant Hematologic and Lymphocytic DisorderUnited States, Canada
-
Millennium Pharmaceuticals, Inc.TerminatedAllogeneic Hematopoietic Stem Cell TransplantationUnited States, Belgium, Sweden, France, Norway
-
Fate TherapeuticsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Chronic Myelogenous Leukemia | Hematologic Malignancies | Acute Graft-versus-host DiseaseUnited States
-
Roswell Park Cancer InstituteCompletedUnspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific | Graft Versus Host DiseaseUnited States
-
NYU Langone HealthRecruitingGraft Vs Host DiseaseUnited States
-
Incyte CorporationTerminatedHematologic MalignanciesUnited States, Spain, France, Italy
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.Completed
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous Leukemia (AML) | Acute Lymphocytic Leukemia (ALL) | Graft vs. Host Disease (GvHD)United States, Canada
-
EVIVE BiotechnologyMemorial Sloan Kettering Cancer CenterCompletedAcute Graft vs Host DiseaseUnited States
-
SoligenixTerminatedAcute Gastrointestinal Graft vs Host DiseaseUnited States
-
Emory UniversityBristol-Myers Squibb; Thrasher Research Fund; Sickle Cell Transplant Advocacy... and other collaboratorsActive, not recruitingGraft Versus Host DiseaseUnited States
-
Mesoblast, Inc.CompletedGraft Vs Host DiseaseUnited States
-
The Canadian Blood and Marrow Transplant GroupNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Graft Versus Host Disease | Secondary MyelofibrosisAustralia, Canada, United States, New Zealand, Saudi Arabia
-
Novartis PharmaceuticalsCompletedCorticosteroid Refractory Acute Graft vs Host DiseaseGermany, Japan, Saudi Arabia, Turkey, United Kingdom, Spain, Canada, Italy, Australia, Austria, France, Korea, Republic of, Hong Kong, Israel, Netherlands, Russian Federation, Denmark, Greece, Taiwan, Norway, Czechia, Bulgaria
-
Lee, StephanieNational Cancer Institute (NCI)CompletedSystemic Scleroderma | Graft Versus Host DiseaseUnited States
-
Enanta Pharmaceuticals, IncTerminatedChronic Hepatitis B Virus InfectionNew Zealand
-
Gilead SciencesCompleted
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Baxalta now part of ShireTerminatedLymphoma | Leukemia | Graft Versus Host DiseaseUnited States, Australia
-
John LevineRecruitingAdverse Effects | Acute Graft vs Host Disease | Allogeneic Bone Marrow TransplantationUnited States, Canada
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand